استمتع بـUnlimited مع Magzter GOLD

استمتع بـUnlimited مع Magzter GOLD

احصل على وصول غير محدود إلى أكثر من 9000 مجلة وصحيفة وقصة مميزة مقابل

$149.99
 
$74.99/سنة

يحاول ذهب - حر

'A Contemporary And Relevant Pharmacy Curriculum Is The Need'

September 1-15, 2017

|

Express Pharma

Dr B Suresh, President, Pharmacy Council of India, speaks on various issues related to pharma education in India and elaborates on the initiative taken by Pharmacy Council of India (PCI) to bridge the gap between industry and academia, in an interview with Swati Rana.

- Swati Rana

'A Contemporary And Relevant Pharmacy Curriculum Is The Need'

Brief us on the current scenario of pharma education in India.

The pharmacy education in India is presently in a very challenging phase. Due to an increase in the growth of the pharma industry, there is a growing need for qualified and highly knowledgeable human resource. As a result, there is now a sudden spurt of interest from the students to pursue pharmacy programme in India. Further, job opportunities for engineering based programmes are on the downslide, making it less attractive for students to pursue engineering as a first choice of career option. The sudden influx of interest and consequent increase of demand has resulted in the rush to start new pharmacy colleges in India in an already overcrowded space. This sudden growth has precipitated issues relating to the quality of education being delivered at these institutions. The Pharmacy Council of India (PCI) has addressed this challenge of quality in pharmacy education through a strategy involving three domains of action: quality assurance, academic and institutional capacity building and more emphasis on experiential education and competency building.

What are the issues faced by PCI?

PCI faces a major challenge with regards to dual regulation of pharmacy education, i.e. by the PCI and All India Council for Technical Education (AICTE). This dual regulation has led to institutions exploiting structural and procedural mechanisms of regulation to their advantage, resulting in a number of litigations. Though the PCI and AICTE have worked out strategies to harmonise their regulations it still does precipitate regulatory challenges that result in not being able to bring about quality advancement. Besides this, the major challenge for pharmacy education in the country relates to the availability of qualified and competent pharmacy teachers that can carry forward the vision of PCI in preparing a pharmacist workforce that is competent, current and relevant.

المزيد من القصص من Express Pharma

Express Pharma

Express Pharma

NEEDLES, PENS AND PRESSURE THE GLP-1 CHALLENGE

As GLP-1 therapies transform diabetes and obesity care, demand for prefilled pens and injectors is soaring. Pharma-device collaborations, analytical innovation, and sustainable design will be key to tackle the growing device bottleneck

time to read

7 mins

November 2025

Express Pharma

Express Pharma

Unified standards and smarter design are key to unlocking next-generation HVAC performance

Current HVAC design relies on a diverse, and sometimes confusing, array of guidelines issued by regulatory bodies such as WHO, EU GMP, ISO 14644, ISPE Baseline, and ASHRAE/ISHRAE.

time to read

2 mins

November 2025

Express Pharma

Express Pharma

Kyasanur Forest Disease - How far is a regulatory approved vaccine?

Dr Priyabrata Pattnaik, Former Deputy MD, Indian Immunologicals, informs about the Kyasanur Forest Disease (KFD), a zoonotic viral hemorrhagic fever endemic to parts of India, particularly along the Western Ghats and discusses the current status of developing a regulatory-approved KFD vaccine in India

time to read

3 mins

November 2025

Express Pharma

Express Pharma

India's biopharma industry charts the road from biosimilars to innovation

Express Pharma hosted the maiden Biopharma Leadership Conclave 2025 and brought together industry leaders to discuss how India can move from being the world's leading producer of generics and biosimilars to becoming a hub for innovative, affordable, and high-quality biologics and advanced therapies

time to read

4 mins

November 2025

Express Pharma

Express Pharma

Digital technologies are quietly transforming HVAC into an intelligent compliance partner

Over the last decade, HVAC standards in pharmaceutical manufacturing have undergone a quiet revolution.

time to read

2 mins

November 2025

Express Pharma

Express Pharma

Direct-to-Retail will increasingly complement traditional pharma distribution

Aqualab has crossed Rs 100 crore in just three years, what have been the key drivers behind this growth, and how does the brand plan to achieve the Rs 250 crore target by FY25-26?Aqualab's journey to Rs 100 crore within three years reflects the strength of a simple yet powerful principle, accessibility through proximity. Our growth has been anchored in three areas: a high-velocity retail network that prioritises last-mile availability, a well-diversified therapeutic portfolio spanning acute and chronic segments, and a strong focus on brand trust built through consistent product quality.

time to read

3 mins

November 2025

Express Pharma

Express Pharma

Guaranteeing continuity of medicine supply through AI innovation

Hari Kiran Chereddi highlights how AI is transforming pharma supply chains to ensure uninterrupted medicine availability

time to read

2 mins

November 2025

Express Pharma

PROSOLV® 730: Directly compressible carrier for lipophilic ingredients

Nearly 90 % of molecules in the discovery pipeline and 40 % of drugs with market approval are poorly water soluble. Poor aqueous solubility can lead to low bioavailability resulting in insufficient plasma levels. Oil-based preparations of these APIs, as well as oily APIs in general, present challenges in terms of solid dosage form manufacturing. PROSOLV® 730 was designed to provide a solution to the formulation of BCS class II and IV APIs. It enables the formulation of lipidic APIs or API-loaded lipid systems by facilitating the adsorption of oil, creating a free-flowing, compactible system that can be further formulated. PROSOLV® 730 is a co-processed, high-functionality excipient comprising MCC SILICA COPOVIDONE

time to read

2 mins

November 2025

Express Pharma

Express Pharma

Ensuring Clean Room Integrity with Prime Clean Reset High-Speed Doors: Minimizing Air Permeability and Leakages

High-speed doors for clean rooms are specialized industrial doors essential for maintaining controlled environments. These doors are engineered to be airtight, creating a reliable barrier between different areas of a facility. Their design ensures durability and minimal maintenance, reducing the frequency of repairs and replacements.

time to read

2 mins

November 2025

Express Pharma

Express Pharma

Reimagining cold chain: How IoT secures every pharma mile

Swarup Bose, Co-founder and CEO, Celcius Logistics points out that as the demand for temperature-sensitive medicines surges, maintaining an unbroken cold chain has never been more critical. IoT is emerging as the game-changer that ensures every vial and vaccine arrives potent, safe, and on time

time to read

3 mins

November 2025

Translate

Share

-
+

Change font size